X. Пациенты, не имеющие клинических признаков заболеваний сердца.

Пациенты без доказанной ИБС, но имеющие 2 и более фактора риска ее развития при выполнении операций промежуточного или высокого кардиального риска требуют аналогичного обследования и периоперационного лечения, как и больные с доказанной ИБС (см. пункт I). Согласно рекомендациям ЕОК проведение стресс-теста перед планируемым вмешательством высокого риска у пациентов с 3-мя и более факторами риска имеет класс доказанности I, уровень С [3].

В отношении назначения с профилактической целью БАБ пациентам с промежуточным риском (1-2 факторами риска) единого мнения нет. В тоже время показано, что назначение БАБ пациентам с низким риском может иметь негативный эффект на смертность.

Послеоперационный мониторинг

Все пациенты с повышенным риском осложнений нуждаются в мониторировании ЭКГ в течении 72 часов после операции. Как правило, изменения на ЭКГ предшествуют клиническому ухудшению

ЛИТЕРАТУРА

1. Devereaux, P.J. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk / P.J. Devereaux, L. Goldman, D.J. Cook et al. // CMAJ. – 2005. – Vol.173 (6). – P. 627-634.

2. Mangano, D. Peri-operative cardiovascular morbidity: new developments. Bailliere's Clin Anaesthesiol 1999;13:335-48.

3. Don Poldermans, Jeroen J.Bax, Eric Boersma et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). European Heart Journal doi:10.1093/eurheartj/ehp337.

4. Eagle, K.A. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery — executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) / K.A. Eagle, P.B. Berger, H. Calkins et al. // J Am Coll Cardiol. – 2002. – Vol.39. – P. 542-653.

5. Boersma E, Kertai M D, Schouten O et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. AmJMed 2005; 118: 1134–1141.

6. Holte K, Kehlet H. Postoperative ileus: a preventable event. BrJSurg 2000; 87: 1480–1493.

7. Lee T H, Marcantonio E R, Mangione C M et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043–1049.

8. Kertai M D, Boersma E, Klein J et al. Optimizing the prediction of perioperative mortality in vascular surgery by using a customized probability model. Arch Intern Med. 2005 Apr 25;165(8):898-904.

9. Preoperative tests. The use of routine preoperative tests for elective surgery. National Institute for Clinical Excellence. Clinical Guideline 3. 2003 Available from: www.nice.org.uk.

10. Noordzij P G, Boersma E, Bax J J et al. Prognostic value of routine preoperative electrocardiography in patients undergoing noncardiac surgery. AmJCardiol 2006; 97: 1103–1106.

11. Eagle, K.A. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) / K.A. Eagle, B.H. Brundage, B.R. Chaitman et al. // Circulation. – 1996. – Vol. 93. – P. 1278-1317.

12. Priebe H J. Perioperative myocardial infarction — aetiology and prevention. BrJAnaesth 2005; 95: 3–19.

13. Диагностика и лечение больных острым инфарктом миокарда с подъемом сегмента ST электрокардиограммы. Национальные клинические рекомендации. Сборник / под ред. Р.Г. Оганова. – М., 2009. – 528 с.

14. Диагностика и лечение стабильной стенокардии. Национальные клинические рекомендации. Сборник / под ред. Р.Г. Оганова. – М., 2009. – 528 с.

15. Management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation. ESC Clinical Practice Guidelines. EHJ 2007;28:1598-1660.

16. Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM, Cobb FR, Pryor DB. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). AmJCardiol 1989;64:651–654.

17. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, Froelicher VF, Leon AS, Pina IL, Rodney R, Simons-Morton DA, Williams MA, Bazzarre T. Exercise standards for testing and training: a statement for health-care professionals from the American Heart Association. Circulation 2001;104:1694–1740.

18. Poldermans D, Boersma E, Bax J J et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying StressEchocardiography Study Group. NEnglJMed 1999; 341: 1789–1794.

19. Devereaux P J, Yang H, Yusuf S et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISEtrial): a randomized controlled trial. Lancet 2008; 371: 1839–1847.

20. Brady A R, Gibbs J S, Greenhalgh R M et al. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. JVascSurg 2005; 41: 602–609.

21. Juul A B, Wetterslev J, Gluud C et al. Effect of perioperative betablockade in patients with diabetes undergoing major non-cardiac surgery: randomized placebocontrolled, blinded multicenter trial. BMJ 2006; 332: 1482.

22. Mangano D T, Layug E L, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. NEnglJMed 1996; 335: 1713–1720.

23. Yang H, Raymer K, Butler R, Parlow J, Roberts R. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. AmHeartJ 2006; 152: 983–990.

24. Zaugg M, Bestmann L, Wacker J et al. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 2007; 107: 33–44.

25. Auerbach A D, Goldman L. b-Blockers and reduction of cardiac events in non-cardiac surgery: scientific review. JAMA 2002; 287: 1435–1444.

26. McGory M L, Maggard M A, Ko C Y. A meta-analysis of perioperative betablockade: what is the actual risk reduction? Surgery 2005;138:171–179.

27. Schouten O, Shaw L J, Boersma E et al. A meta-analysis of safety and effectiveness of perioperative beta-blocker use for the prevention of cardiac events in different types of noncardiac surgery. CoronArteryDis 2006;17:173–179.

28. Stevens R D, Burri H, Tramer M R. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. AnesthAnalg 2003;97:623–633.

29. Bangalore S, Wetterslev J, Pranesh S et al. Perioperative b-blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 2008;372:1962–1976.

30. Devereaux P J, Beattie W S, Choi P T et al. How strong is the evidence for the use of perioperative betablockers in non-cardiac surgery? Systematic review and meta-analysis of randomized controlled trials. BMJ 2005;331:313–321.

31. Wiesbauer F, Schlager O, Domanovits H et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis. AnesthAnalg 2007;104:27–41.

32. Щукин Ю.В., Вачев А.Н., Суркова Е.А. и др. Роль β-блокаторов и If-ингибитороа ивабрадина в снижении частоты развития кардиальных осложнений после операции каротидной эндартерэктомии // Кардиология. – Москва, 2008. – Т. 48. - № 5. – С. 56-59.

33. Hindler K, Shaw A D, Samuels J et al. Improved post-operative outcomes associated with preoperative statin therapy. Anesthesiology 2006;105:1260–1272;quiz1289–1290.

34. Williams T M, Harken A H. Statins for surgical patients. AnnSurg 2008;247:30–37.

35. Schouten O, Hoeks S E, Welten G M et al. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. AmJCardiol 2007;100:316–320.

36. Dunkelgrun M, Boersma E, Schouten O et al. Bisoprolol and fluvastin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing non-cardiovascular surgery; a randomized controlled trial (DECREASE-IV). AnnSurg 2009;249:921–926.

37. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Национальные клинические рекомендации. Сборник / под ред. Р.Г. Оганова. – М., 2009. – 528 с.

38. Burger W, Chemnitius J M, Kneissl G D, Rucker G. Low-dose aspirin for secondary cardiovascular prevention—cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation—review and meta-analysis. JInternMed 2005;257:399–414.

39. Biondi-Zoccai G G, Lotrionte M, Agostoni P et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. EurHeartJ 2006;27:2667–2674.

40. Douketis J D, Berger P B, Dunn A S et al.The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8^th Edition). Chest 2008;133(6Suppl):299S–339S.

41. Coriat P, Daloz M, Bousseau D, Fusciardi J, Echter E, Viars P. Prevention of intraoperative myocardial ischemia during noncardiac surgery with intravenous nitroglycerin. Anesthesiology 1984;61:193–196.

42. Дупляков ДВ, Лебедев ПА. Нагрузочное тестирование: принципы и клиническая интерпретация // Самара, Издательское объединение «Медицина», 2005. – 80 с.

43. Serruys P W, Morice M C, Kappetein A P et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. NEnglJ Med 2009;360:961–972.

44. Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (ACC/AHA/ESC 2006 Guidelines for Management of Patients With). ESC Clinical Practice Guidelines // Europace 2006;8:746-837.

45. Рекомендации Всероссийского научного общества специалистов по клинической электрофизиологии, аритмологии и кардиостимуляции. М.: ООО «Издательский дом Золотой абрикос», 2005. — 238 с.

46. Supraventricular Arrhythmias (ACC/AHA/ESC Guidelines for the Management of Patients with). ESC Clinical Practice Guidelines // EHJ 2003;24:1857-1897.

47. Balser J R. Perioperative arrhythmias: incidence, risk assessment, evaluation, and management. CardElectrophysiolRev 2002;6:96–99.

48. Erdman S, Levinsky L, Servadio C et al. Safety precautions in the management of patients with pacemakers when electrocautery operations are performed. SurgGynecolObstet 1988;167:311–314.

49. Potyk D, Raudaskoski P. Preoperative cardiac evaluation for elective noncardiac surgery. ArchFamMed 1998;7:164–173.

50. Simon A B. Perioperative management of the pacemaker patient. Anesthesiology 1977;46:127–131.

51. Shapiro W A, Roizen M F, Singleton M A et al. Intraoperative pacemaker complications. Anesthesiology 1985;63:319–322.

52. Management of Valvular Heart Disease. ESC Clinical Practice Guidelines // EHJ 2007;28:230-268.

53. Infective Endocarditis (Guidelines on Prevention, Diagnosis and Treatment of). ESC Clinical Practice Guidelines // EHJ 2009;30:2369-2413 - doi:10.1093/eurheartj/ehp285.

54. Антитромботическая терапия у больных со стабильными проявлениями атеротромбоа. Российские рекомендации // Кардиоваскулярная терапия и профилактика, 2009; 8(6), Приложение 6.

55. Диагностика и лечение артериальной гипертензии. Национальные клинические рекомендации. Сборник / под ред. Р.Г. Оганова. – М., 2009. – 528 с.

56. Weksler N, Klein M, Szendro G et al. The dilemma of immediate preoperative hypertension: to treat and operate, or to postpone surgery? JClinAnesth 2003;15:179–183.

57. Российские национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (второй пересмотр). Москва, 2007.

58. Feringa H H, Bax J J, Schouten O, Poldermans D. Protecting the heart with cardiac medication in patients with left ventricular dysfunction undergoing major non-cardiac vascular surgery. SeminCardiothoracVascAnesth 2006;10:25–31.

59. Hindler K, Shaw A D, Samuels J et al. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 2006;105:1260–1272;quiz1289–1290.

60. Williams T M, Harken A H. Statins for surgical patients. AnnSurg 2008;247:30–37.

61. Schouten O, Hoeks S E, Welten G M et al. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. AmJCardiol 2007;100:316–320.

27